Conference Coverage

VIDEO: Biomarker may reveal lymphoma risk in Sjögren’s syndrome


 

AT ACR 2014

References

BOSTON – Low expression of protein A20 in minor salivary gland tissue appears to be associated with lymphomas in patients with primary Sjögren’s syndrome.

In an interview after his late-breaker presentation at the annual meeting of the American College of Rheumatology, Dr. Svein Joar A. Johnsen of Stavanger (Norway) University Hospital, discussed the implications of his findings and the search for biomarkers of lymphoma risk in these patients.

mdales@frontlinemedcom.com

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

FDA panel votes against panobinostat as add-on therapy for multiple myeloma
MDedge Hematology and Oncology
Superior vena cava syndrome as an initial presentation of low-grade follicular lymphoma
MDedge Hematology and Oncology
EZH2 inhibitor is active in NHL with wild-type EZH2
MDedge Hematology and Oncology
Potential treatment method induces severe side effects
MDedge Hematology and Oncology
Group silences microRNA to treat DLBCL
MDedge Hematology and Oncology
Infection may cause implant-associated ALCL
MDedge Hematology and Oncology
Hospice cuts cost and use of care for cancer patients
MDedge Hematology and Oncology
Group develops cancer health literacy tool
MDedge Hematology and Oncology
Hematology drugs on the fast track
MDedge Hematology and Oncology
Aspartame, sweetened drinks don’t increase risk of NHL
MDedge Hematology and Oncology